News|Articles|October 2, 2004
- Pharmaceutical Technology-10-02-2004
- Volume 28
- Issue 10
Drug Development Linked More Closely to Diagnostics
Author(s)Jill Wechsler
FDA and industry discuss proposals for regulating combination diagnostics, medical devices, and pharmacogenomic-based drug products.
Advertisement
Articles in this issue
about 21 years ago
A Novel Freeze Pelletization Technique for Preparing Matix Pelletsabout 21 years ago
Aseptic Processing: A Review of Current Industry Practiceabout 21 years ago
Can Inserts Be Improved?about 21 years ago
In The Spotlight-October 2004about 21 years ago
October 2004about 21 years ago
The High Price of SuccessNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Challenges for the Global Manufacturing of Vaccines
5
